DLTR
52
8
OXY
42
17
IBM
53
2
EMR
57
7
SNA
56
3
NDAQ
46
2
AFL
34
6
MSFT
55
2
NTRS
35
10
USB
50
3
PFE
37
4
DNB
72
4
EXR
42
5
NWSA
69
4
CTAS
36
8
EXPE
83
8
FOXA
67
5
ILMN
31
4
SYF
78
7
HBI
53
4
DLTR
52
8
OXY
42
17
IBM
53
2
EMR
57
7
SNA
56
3
NDAQ
46
2
AFL
34
6
MSFT
55
2
NTRS
35
10
USB
50
3
PFE
37
4
DNB
72
4
EXR
42
5
NWSA
69
4
CTAS
36
8
EXPE
83
8
FOXA
67
5
ILMN
31
4
SYF
78
7
HBI
53
4
Financhill
Back

Knightscope 10K Form

Sell
28

KSCP
Knightscope

Last Price:
$13.25
Seasonality Move:
-44.04%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive KSCP News And Ratings

See the #1 stock for the next 7 days that we like better than KSCP

KSCP Financial Statistics

Sales & Book Value

Annual Sales: $12.8M
Cash Flow: $-4.7M
Price / Cash Flow: 0
Annual Sales: $2.59
Price / Book: 5.53

Profitability

EPS (TTM): -13.97000
Net Income (TTM): $-31.3M
Gross Margin: $-2M
Return on Equity: -351.56%
Return on Assets: -128.83%

Knightscope Earnings Forecast

Key Knightscope Financial Ratios

  • The Gross Profit Margin over the past 5 years for KSCP is -15.82%.
  • The Selling, General & Administrative Expenses for KSCP have been equal to 138.81% of Gross Profit Margin.
  • The Research & Development expenses have been 49.63% of Revenue.
  • The Interest Expense is -2.49% of Operating Income.
  • The Net Earning history of KSCP is -172.84% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 2 years.

Knightscope Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Commercial Services & Supplies
Sector: Industrials
Current Symbol: KSCP
Website: knightscope.com

Debt

Debt-to-Equity Ratio: 0.72
Current Ratio: 1
Quick Ratio: 0.66

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

KSCP Technical Analysis vs Fundamental Analysis

Sell
28
Knightscope (KSCP) is a Sell

Is Knightscope a Buy or a Sell?

  • Knightscope stock is rated a Sell
    The current Knightscope [KSCP] share price is $13.40. The Score for KSCP is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.